Profile and potential role of novel metabolite biomarkers, especially indoleacrylic acid, in pathogenesis of neuromyelitis optica spectrum disorders
Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system (CNS) inflammatory and demyelinating disorder that can lead to serious disability and mortality. Humoral fluid biomarkers with specific, convenient, and efficient profiles that could characterize and m...
Main Authors: | Jiangping Bian, Jiali Sun, Haoxiao Chang, Yuzhen Wei, Hengri Cong, Mengyuan Yao, Fuyao Xiao, Huabing Wang, Yaobo Zhao, Jianghong Liu, Xinghu Zhang, Linlin Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1166085/full |
Similar Items
-
Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
by: Yupeng Wang, et al.
Published: (2023-03-01) -
Neuromyelitis optica spectrum disorders in pediatric patients
by: Yu. V. Tokareva, et al.
Published: (2018-04-01) -
The in-vivo study of pain in neuromyelitis optica
by: Tackley, G
Published: (2017) -
Pregnancy and neuromyelitis optica
by: Qiu-ying MA, et al.
Published: (2016-10-01) -
Neuromyelitis Optica: A Case Report
by: Wei-Chia Chia, et al.
Published: (2010-12-01)